subject area of
- <p>Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease</p> Academic Article
- A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study). Academic Article
- A systematic review of adverse drug events associated with administration of common asthma medications in children Academic Article
- Acute asthma intervention: Insights from the STAY study Academic Article
- Antiinflammatory Effects of Long-Acting β 2 -Agonists in Patients With Asthma Academic Article
- Are inhaled longacting β2 agonists detrimental to asthma? Academic Article
- Asthma maintenance and reliever therapy Academic Article
- COPD treatment pathways in France: a retrospective analysis of electronic medical record data from general practitioners Academic Article
- Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β2-agonist dual therapy in a primary care setting in England Academic Article
- Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England Academic Article
- Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Dual Therapy in a Primary Care Setting in England Academic Article
- Chronic β2-adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca2+-ATPase protein and activity Academic Article
- Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain Academic Article
- Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting Academic Article
- Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis Academic Article
- Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids Academic Article
- Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease Academic Article
- Coronary β2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans: novel insights from an in vivo intravascular ultrasound study Academic Article
- Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy Academic Article
- Cost-effectiveness of umeclidinium as add-on to ICS/LABA therapy in COPD: A UK perspective Academic Article
- Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England Academic Article
- Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma Academic Article
- Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study Academic Article
- Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice Guideline Academic Article
- Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment Academic Article
- Fluticasone Furoate–Vilanterol 100-25 mcg Compared with Fluticasone Furoate 100 mcg in Asthma: A Randomized Trial Academic Article
- Formoterol as reliever medication in asthma: a post-hoc analysis of the subgroup of the RELIEF study in East Asia Academic Article
- Inhaled Corticosteroids for Asthma Therapy in Young Children: Does Aerosol Particle Size Matter? Academic Article
- Intramuscular β2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury Academic Article
- Long-Acting β2-Agonist Step-off in Patients With Controlled Asthma Academic Article
- Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps Academic Article
- Potentiation of long-acting β2-agonist and glucocorticoid responses in human airway epithelial cells by modulation of intracellular cAMP Academic Article
- Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting β2-agonist, in patients with mild asthma Academic Article
- Quantifying the Economic Impact of Delayed Multiple-Inhaler Triple Therapy Initiation in Patients with COPD: A Retrospective Cohort Study of Linked Electronic Medical Record and Hospital Administrative Data in England Academic Article
- Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice Academic Article
- Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events Academic Article
- Safety of formoterol in asthma clinical trials: an update Academic Article
- Safety of long‑acting β2‑agonists: a little bit of history. Dr. Paul O’Byrne in an interview with Dr. Roman Jaeschke: part 1 Academic Article
- Safety of long‑acting ß2‑agonists: current state of knowledge. Dr. Paul O’Byrne in an interview with Dr. Roman Jaeschke: part 2 Academic Article
- The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK Academic Article
- The paradoxes of asthma management: time for a new approach? Academic Article
- Therapeutic strategies to reduce asthma exacerbations Academic Article
- Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England Academic Article
- Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma Academic Article
- β<sub>2</sub>-Agonists for Asthma: The Pediatric Perspective Academic Article
- β2 Déjà Vu Academic Article